C. R. Bard
Clinical trials sponsored by C. R. Bard, explained in plain language.
-
New antiseptic cloth shows promise in killing germs before surgery
Disease control CompletedThis study tested whether a special cloth with a new antiseptic (octenidine) can reduce germs on the skin before surgery better than standard cloths. About 145 healthy adults took part, and researchers measured germ levels on the abdomen and groin after 10 minutes and 6 hours. Th…
Phase: PHASE2 • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 26, 2026 04:44 UTC
-
New device aims to improve dialysis access for kidney patients
Disease control CompletedThis study tested a new device called FLEX-1 to create a blood vessel connection (fistula) for dialysis in 17 people with advanced chronic kidney disease. The goal was to see if the device is safe and works well for hemodialysis. The study focused on complication rates and whethe…
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New stent graft aims to keep dialysis lifelines working longer
Disease control CompletedThis study looked at a special tube called a stent graft used to treat narrowed veins in people who need dialysis. The goal was to see if it safely keeps the dialysis access open longer. About 100 adults with an arm fistula took part. The results help doctors understand how well …
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New Needle-Free fistula device shows promise for dialysis patients
Disease control CompletedThis study tested a new device that creates a connection between an artery and vein using a needle instead of surgery, making dialysis access easier. It involved 24 adults with kidney failure who needed dialysis. The goal was to see if the device worked safely and could offer mor…
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New needle-free method for dialysis access tested in kidney patients
Disease control CompletedThis study tested a new device called the FLEX System that creates a connection between an artery and a vein using a tube inserted through the skin, instead of surgery. The goal was to see if this method is safe and works well for people with chronic kidney disease who need dialy…
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New skin cleaner put to the test before surgery
Disease control CompletedThis study tested a new skin-cleansing product to see how well it kills bacteria before surgery. It compared the new product to an already-approved product and a placebo (no active ingredient). The goal was to measure the reduction in bacteria on the skin of 60 healthy volunteers…
Phase: PHASE3 • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New device aims to simplify dialysis access for kidney patients
Disease control CompletedThis study tested a new device called FLEX-1 in 16 adults with advanced chronic kidney disease who need dialysis. The device is used to create a special connection between an artery and a vein (called an arteriovenous fistula) that allows for easier and more reliable dialysis ses…
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New device aims to simplify dialysis access for kidney patients
Disease control CompletedThis study tested a new system (everlinQ) to create a connection between an artery and vein in the arm for dialysis. 32 adults with kidney failure who needed dialysis took part. The goal was to see if the connection matured properly and safely, so patients could receive dialysis …
Phase: NA • Sponsor: C. R. Bard • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New catheter offers hope for cancer patients with breathing trouble
Symptom relief CompletedThis small pilot study tested a new catheter to safely drain fluid from the chest in 10 adults with cancer-related pleural effusions. The goal was to ease symptoms like shortness of breath by removing fluid buildup. Researchers checked for side effects and whether the catheter he…
Phase: NA • Sponsor: C. R. Bard • Aim: Symptom relief
Last updated May 26, 2026 04:43 UTC
-
Silver-Lined catheter shows promise in keeping cancer Patients' lungs Fluid-Free
Symptom relief CompletedThis study tested a new silver-coated tube (catheter) placed in the chest to prevent fluid from building up again in cancer patients with malignant pleural effusion. 119 adults with recurrent, symptomatic fluid around the lungs were randomly assigned to get either the silver-coat…
Phase: NA • Sponsor: C. R. Bard • Aim: Symptom relief
Last updated May 26, 2026 04:43 UTC
-
New skin prep tested for injection safety
Knowledge-focused CompletedThis study tested how well a specific skin cleaner (ChloraPrep One-Step Frepp) kills bacteria on the skin before an injection. 25 healthy adults took part. Researchers measured the drop in bacteria 30 seconds and 10 minutes after cleaning. The goal was to see if the cleaner works…
Phase: PHASE4 • Sponsor: C. R. Bard • Aim: Knowledge-focused
Last updated May 26, 2026 04:45 UTC
-
New catheter study sees how well teens can use them
Knowledge-focused CompletedThis study looked at how well two external catheter devices (PureWick for males and PureWick Flex for females) work in healthy teenagers aged 12 to 21. The main goal was to measure how much urine the device catches compared to what leaks out. Researchers also asked participants h…
Phase: NA • Sponsor: C. R. Bard • Aim: Knowledge-focused
Last updated May 26, 2026 04:31 UTC
-
Skin cleaner tested for surgery prep
Knowledge-focused CompletedThis study tested how well a skin cleaner called ChloraPrep One-Step kills bacteria on the skin before surgery. 27 healthy adults took part. Researchers measured the change in bacteria count 10 minutes after applying the cleaner. The goal was to see if it reduces germs effectivel…
Phase: PHASE4 • Sponsor: C. R. Bard • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC
-
Scientists check What's left in bandages after a week
Knowledge-focused CompletedThis study looked at how much of the germ-killing ingredient chlorhexidine remains in special bandages after being worn for 7 days. It also checked for a chemical called PCA that can form in these bandages. 45 healthy adults took part, and the goal was simply to measure these lev…
Phase: PHASE1 • Sponsor: C. R. Bard • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC